Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Nuclear Medicine and Molecular Imaging
>
2022
>
42
>
2
Volume:
42
Issue:
2
1. Preclinical evaluation of 89Zr labeled Daratumumab for imaging diagnosis of multiple myeloma
Page:68—73
2. Pretargeted immunoPET imaging with epidermal growth factor receptor monoclonal antibody in mouse models
Page:74—79
3. SPECT/CT imaging of PD-L1 expression in non-small cell lung cancer based on 99Tc m labeled anti-PD-L1 nanoantibodies
Page:80—83
4. Recombinant human thyroid-stimulating hormone for post-operative assessment in patients with low- to intermediate-risk differentiated thyroid cancer: results of phase Ⅰ study
Page:84—89
5. Clinical significance of telomerase reverse transcriptase promoter mutation in radioactive iodine refractory papillary thyroid cancer
Page:90—95
6. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using 99Tc m-3PRGD 2 imaging in comparison to 18F-FDG imaging
Page:96—103
7. Recent advancement of clinical immunoPET imaging in tumor diagnosis and therapy
Page:113—117
8. 18F-FDG PET/CT in detecting immune-related adverse events
Page:118—121